Jci_page_head_homepage_01 Jci_page_head_homepage_02
Jennifer L. Gommerman, Fabienne Mackay, Elina Donskoy, Werner Meier, Pauline Martin, Jeffrey L. Browning
Published in Volume 110, Issue 9
J Clin Invest. 2002; 110(9):1359–1369 doi:10.1172/JCI15975
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1

FDC networks in the spleen are eliminated in animals treated with LTβR-Ig. Representative spleens from untreated (a and b), treated (8 mg/kg LTβR-Ig) (c and d), and recovery animals (8 mg/kg treatment followed by 3-month recovery) (e and f) were stained with anti-CD35 Ab’s and developed with AP-red. Spleens were counterstained with Giemsa and photographed at ×25 (a, c, e) or ×100 (b, d, f).